Literature DB >> 26226578

Blood-cell bioenergetics are associated with physical function and inflammation in overweight/obese older adults.

Daniel J Tyrrell1, Manish S Bharadwaj1, Cynthia G Van Horn1, Anthony P Marsh2, Barbara J Nicklas1, Anthony J A Molina3.   

Abstract

BACKGROUND: Physical function and strength decline with age and lead to limited mobility and independence in older adults. Alterations in mitochondrial function are thought to underlie numerous age-related changes, including declining physical ability. Recent studies suggest that systemic changes in bioenergetic capacity may be reported by analyzing mitochondrial function in circulating cells. The objective of this study was to determine whether the bioenergetic capacity of peripheral blood mononuclear cells (PBMCs) is related to differences in physical function among older, overweight/obese, adults. To address this, we tested the hypothesis that greater PBMC respirometric capacity would be associated with better physical function, muscular strength, leg lean mass, and muscle quality. Furthermore, we tested whether the respirometric capacity of PBMCs is related to cellular composition and inflammatory status reported by interleukin-6 (IL-6).
METHODS: Fasted PBMC respiration (pmol/min/500,000 cells), expanded short physical performance battery (Ex-SPPB), peak knee extensor (KE) strength (Nm), grip strength (kg), leg lean mass (kg, via dual energy X-ray absorptiometry [DXA]), muscle quality (Nm/kg), and plasma IL-6 (pg/mL) were analyzed in 15 well-functioning, community-dwelling, sedentary overweight/obese older men (n=9) and women (n=6) aged 65 to 78 (mean 68.3 ± 3.5 years). Pearson and partial correlations were calculated to determine associations between PBMC respiration and these variables.
RESULTS: Higher maximal respiration of PBMCs was associated with better Ex-SPPB (r=0.58, p=0.02), greater KE strength (r=0.60, p=0.02), greater grip strength (r=0.52, p=0.05) and lower IL-6 (r=-0.58, p=0.04). Higher spare respiratory capacity was associated with better Ex-SPPB (r=0.59, p=0.02), greater KE strength (r=0.60, p=0.02), greater grip strength (r=0.54, p=0.04), greater leg muscle quality (r=0.56, p=0.04), and lower IL-6 (r=-0.55, p=0.05). Monocyte and lymphocyte counts were not related to PBMC respiratory capacity.
CONCLUSIONS: Our results indicate that respirometric profiles of readily obtainable blood cells are associated with physical function and strength. Future studies should be undertaken in order to determine whether blood-based bioenergetic profiling can provide an objective index of systemic mitochondrial health.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioenergetics; Blood; Inflammation; Mitochondria; Physical function

Mesh:

Substances:

Year:  2015        PMID: 26226578      PMCID: PMC6471587          DOI: 10.1016/j.exger.2015.07.015

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  32 in total

Review 1.  The bioenergetics of inflammation: insights into obesity and type 2 diabetes.

Authors:  K N Keane; E K Calton; R Carlessi; P H Hart; P Newsholme
Journal:  Eur J Clin Nutr       Date:  2017-04-12       Impact factor: 4.016

2.  Platelet bioenergetics correlate with muscle energetics and are altered in older adults.

Authors:  Andrea Braganza; Catherine G Corey; Adam J Santanasto; Giovanna Distefano; Paul M Coen; Nancy W Glynn; Seyed-Mehdi Nouraie; Bret H Goodpaster; Anne B Newman; Sruti Shiva
Journal:  JCI Insight       Date:  2019-05-23

3.  Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.

Authors:  Natalia Dixon; Ting Li; Brandon Marion; Denise Faust; Stephen Dozier; Anthony Molina; Sean Rudnick; Herbert L Bonkovsky
Journal:  Mol Genet Metab       Date:  2019-05-20       Impact factor: 4.797

4.  Developing a clinical and biological measures of aging core: Cancer and Aging Research Group infrastructure.

Authors:  Thuy T Koll; Allison Magnuson; William Dale; Mark A LaBarge; Corinne R Leach; Supriya Mohile; Hyman Muss; Margaret Sedenquist; Heidi D Klepin
Journal:  J Geriatr Oncol       Date:  2019-09-16       Impact factor: 3.599

5.  A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.

Authors:  Timothy S Pardee; Rebecca G Anderson; Kristin M Pladna; Scott Isom; Lais P Ghiraldeli; Lance D Miller; Jeff W Chou; Guangxu Jin; Wei Zhang; Leslie R Ellis; Dmitriy Berenzon; Dianna S Howard; David D Hurd; Megan Manuel; Sarah Dralle; Susan Lyerly; Bayard L Powell
Journal:  Clin Cancer Res       Date:  2018-02-06       Impact factor: 12.531

6.  Analyzing mitochondrial function in human peripheral blood mononuclear cells.

Authors:  Chao-Pin Hsiao; Charles Hoppel
Journal:  Anal Biochem       Date:  2018-03-02       Impact factor: 3.365

7.  Exercise Performance, Muscle Oxygen Extraction and Blood Cell Mitochondrial Respiration after Repeated-Sprint and Sprint Interval Training in Hypoxia: A Pilot Study.

Authors:  Hannes Gatterer; Verena Menz; Eduardo Salazar-Martinez; Zuzana Sumbalova; Luiz Felipe Garcia-Souza; Beáta Velika; Erich Gnaiger; Martin Burtscher
Journal:  J Sports Sci Med       Date:  2018-08-14       Impact factor: 2.988

8.  AGS and NIA Bench-to Bedside Conference Summary: Osteoporosis and Soft Tissue (Muscle and Fat) Disorders.

Authors:  Cathleen Colón-Emeric; Heather E Whitson; Sarah D Berry; Roger A Fielding; Denise K Houston; Douglas P Kiel; Clifford J Rosen; Kenneth L Seldeen; Elena Volpi; James P White; Bruce R Troen
Journal:  J Am Geriatr Soc       Date:  2019-12-02       Impact factor: 5.562

Review 9.  Blood-based bioenergetics: An emerging translational and clinical tool.

Authors:  Andrea Braganza; Gowtham K Annarapu; Sruti Shiva
Journal:  Mol Aspects Med       Date:  2019-12-18

10.  Heterochronic Parabiosis: Old Blood Induces Changes in Mitochondrial Structure and Function of Young Mice.

Authors:  Jenny L Gonzalez-Armenta; Ning Li; Rae-Ling Lee; Baisong Lu; Anthony J A Molina
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-02-25       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.